Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    NCT01205438
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   Connective Tissue Disease;   Autoimmune Disease
Interventions: Drug: LY2127399;   Drug: Placebo every 2 weeks;   Drug: Placebo every 4 weeks
2 Active, not recruiting On Open-Label Study in Participants With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   Connective Tissue Disease;   Autoimmune Disease
Interventions: Drug: LY2127399;   Drug: Placebo

Indicates status has not been verified in more than two years